Skip to main content

Movement Disorders Program News

At CHOP, you have access to one of the largest teams dedicated to caring for movement disorders. Our team has a high level of understanding of these complex conditions.

Contact us

FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy

Aug 22, 2023

For decades, doctors and researchers have been working diligently to discover new treatments and provide more options for patients with Duchenne muscular dystrophy (DMD), a debilitating genetic disease that ravages the muscles in the body and leads to a loss of movement and coordination.

Children’s Hospital of Philadelphia Joins KidsX, Global Leader in Pediatric Digital Health Innovation, to Amplify Digital Transformation Efforts

Jun 27, 2023

Children’s Hospital of Philadelphia (CHOP) has announced that the organization is now a part of KidsX, a global leader in pediatric digital health innovation. KidsX facilitates collaboration between elite children’s hospitals, providers, payors, investors, entrepreneurs, and corporate partners to solve the most pressing problems in pediatric care delivery.

Jump back to top